Talkspace, Inc. (TALK)
NASDAQ:TALK
Want to see TALK full AI Analyst Report?
TALK Stock Chart & Stats
$5.18
-$0.06(-1.90%)
At close: 4:00 PM EST
$5.18
-$0.06(-1.90%)
Day’s Range― - ―
52-Week Range$2.22 - $5.23
Previous CloseN/A
Volume269.09K
Average Volume (3M)1.46M
Market Cap
$874.42M
Enterprise Value$839.65M
Total Cash (Recent Filing)$84.21M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)750.6
Beta1.03
Next Earnings
Aug 10, 2026EPS Estimate
0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding167,512,570
10 Day Avg. Volume1,515,547
30 Day Avg. Volume1,460,187
Financial Highlights & Ratios
PEG Ratio0.13
Price to Book (P/B)5.22
Price to Sales (P/S)2.67
P/FCF Ratio-290.17
Enterprise Value/Market Cap0.96
Enterprise Value/Revenue3.52
Enterprise Value/Gross Profit8.34
Enterprise Value/Ebitda135.49
Forecast
1Y Price Target
$5.25Price Target Upside1.35% Upside
Rating ConsensusHold
Number of Analyst Covering6
EPS Forecast (FY)0.14
Revenue Forecast (FY)$282.24M
Bulls Say, Bears Say
Bulls Say
Balance Sheet Strength (effectively Zero Debt)Effectively zero debt gives Talkspace durable financial flexibility to fund operations, product development, and strategic moves without heavy refinancing risk. This low leverage supports multi-quarter execution on payor expansion and M&A integration, and reduces solvency risk during reimbursement cycles.
Accelerating Payor Business And Broad CoverageRapid, recurring payor growth and large coverage (200M+ lives) create a structurally more predictable revenue base than consumer cash-pay. Strong payor traction supports durable revenue scale, higher retention, and operating leverage that can sustain improved margins over several quarters as contracts and utilization deepen.
Product And Clinical Innovation Boosting EngagementMeasured gains in engagement from AI, Talkcast, and expanded psychiatry increase stickiness and care continuity, which are structural drivers of lifetime value. Sustained clinical innovation enhances competitive differentiation, aids payor retention, and supports higher session frequency and long-term revenue per member.
Bears Say
Negative Free Cash Flow And Weak Cash ConversionPersistent negative free cash flow despite positive operating cash implies reinvestment needs or working-capital strain that consume cash. Over multiple quarters this can limit discretionary spending, extend reliance on external financing or acquirers, and constrain capital for product commercialization or Medicare investments.
Gross Margin Compression From Payor MixA structural shift toward payor contracts can compress gross margins if reimbursement rates are lower than cash-pay. Even with operating leverage, sustained mix-driven margin headwind may limit ultimate profitability and require higher volumes or cost reductions to reach targeted exit margins over multiple quarters.
Medicare/Medicare Advantage Penetration Is DifficultMedicare/MA represents a sizable addressable market but requires substantial product, distribution, and contracting effort. Slow penetration demands ongoing investment and longer payback periods, which can temper medium-term growth and raise execution risk as management allocates resources across payor, employer, and product priorities.
Talkspace News
TALK FAQ
What was Talkspace, Inc.’s price range in the past 12 months?
Talkspace, Inc. lowest stock price was $2.22 and its highest was $5.23 in the past 12 months.
What is Talkspace, Inc.’s market cap?
Talkspace, Inc.’s market cap is $874.42M.
When is Talkspace, Inc.’s upcoming earnings report date?
Talkspace, Inc.’s upcoming earnings report date is Aug 10, 2026 which is in 67 days.
How were Talkspace, Inc.’s earnings last quarter?
Talkspace, Inc. released its earnings results on May 05, 2026. The company reported $0.02 earnings per share for the quarter, missing the consensus estimate of $0.022 by -$0.002.
Is Talkspace, Inc. overvalued?
According to Wall Street analysts Talkspace, Inc.’s price is currently Undervalued.
Does Talkspace, Inc. pay dividends?
Talkspace, Inc. does not currently pay dividends.
What is Talkspace, Inc.’s EPS estimate?
Talkspace, Inc.’s EPS estimate is 0.03.
How many shares outstanding does Talkspace, Inc. have?
Talkspace, Inc. has 167,512,570 shares outstanding.
What happened to Talkspace, Inc.’s price movement after its last earnings report?
Talkspace, Inc. reported an EPS of $0.02 in its last earnings report, missing expectations of $0.022. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Talkspace, Inc.?
Currently, no hedge funds are holding shares in TALK
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Talkspace Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$5.25 (1.35% Upside)
$5.25 (1.35% Upside)
Blogger Sentiment
Bullish
TALK Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 1.5M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days >0.1%
Last 30 Days ▼ 5.9%
Last 30 Days ▼ 5.9%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
52.78%
12-Months-Change
Fundamentals
Return on Equity
1.03%
Trailing 12-Months
Asset Growth
1.45%
Trailing 12-Months
Company Description
Talkspace, Inc.
Talkspace, Inc. operates as a virtual behavior healthcare company. It delivers healthcare through encrypted web and mobile platform. The company offers treatment options for every need, including psychiatry or adolescent, individual, or couples therapy. The members can send text, video, and voice messages to their therapists and engage in live video sessions. Talkspace, Inc. is based in New York, New York.
TALK Company Deck
TALK Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presents strong top-line growth, accelerated Payor traction, significant adjusted EBITDA expansion and operational improvements, supported by product innovation (AI, Talkcast, psychiatry expansion) and M&A (Wisdo). There are manageable execution risks: near-term gross margin pressure from mix, reduced cash after buybacks and acquisition, deliberate de-emphasis of Consumer revenue, and uncertainty around TalkAI commercialization and Medicare penetration. Overall, the positives — recurring Payor growth, margin expansion, and confident 2026 guidance — materially outweigh the listed challenges.View all TALK earnings summariesTALK Stock 12 Month Forecast
Average Price Target
$5.25
▲(1.35% Upside)
Technical Analysis
Acadia Healthcare
―
Cross Country Healthcare
―
Pediatrix Medical Group
―
COMPASS Pathways
―
Lifestance Health Group
―
Ownership Overview
19.03% Insiders
15.46% Mutual Funds
27.53% Other Institutional Investors
28.12% Public Companies and
Individual Investors